US 9644179
Use of PDL1 expressing cells to convert T cells into regulatory T cells
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 9644179 (Use of PDL1 expressing cells to convert T cells into regulatory T cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K40/11, A61K40/22